Related Experiment Video
Updated: Feb 15, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
Clinton Yam1, Rashmi K Murthy1, Vicente Valero1
1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building, CPB5.3542, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.
Abstract:
Background Tipifarnib is an orally active, competitive inhibitor of farnesyltransferase which has shown encouraging signs of activity either alone or when combined with other agents. Clinical studies of tipifarnib in combination with anti-estrogen therapy have yielded disappointing results. In contrast, tipifarnib appears to be synergistic in combination with anthracycline based chemotherapy. Here we report the results of the first prospective phase II trial evaluating the efficacy of the novel combination of tipifarnib and gemcitabine in the treatment of metastatic breast cancer. Patients and Methods 30 postmenopausal women with metastatic breast cancer were treated on a 21-day cycle with tipifarnib 300 mg PO twice daily from days 1 through 14. Gemcitabine was administered intravenously at a dose of 1000 mg/m2 on days 1 and 8. Patients were treated until disease progression or unacceptable toxicity. Results There was one complete response and four partial responses yielding an objective response rate of 16.7%. Median progression-free survival and overall survival was 2.5 months (95% confidence interval: 1.6-5.7 months) and 13.1 months (95% confidence interval: 9.1-20.6 months), respectively. 40% of patients experienced grade 4 neutropenia in this study. Conclusion The combination of tipifarnib and gemcitabine is not well tolerated with high rates of myelosuppression and is not more effective than gemcitabine monotherapy in the treatment of metastatic breast cancer.
Insights
The combination of tipifarnib and gemcitabine showed limited efficacy in metastatic breast cancer, with a 16.7% response rate. This novel combination therapy also resulted in high rates of myelosuppression, indicating poor tolerability.
Area of Science:
- Oncology
- Pharmacology
Background:
- Tipifarnib, a farnesyltransferase inhibitor, shows promise in combination therapies.
- Previous trials with anti-estrogen therapy were disappointing, but synergy with anthracyclines was observed.
Purpose of the Study:
- To evaluate the efficacy and safety of tipifarnib combined with gemcitabine in metastatic breast cancer.
Main Methods:
- A prospective Phase II trial involved 30 postmenopausal women with metastatic breast cancer.
- Patients received tipifarnib (300 mg PO BID days 1-14) and gemcitabine (1000 mg/m2 IV days 1 and 8) on 21-day cycles.
Main Results:
- The objective response rate was 16.7% (1 complete response, 4 partial responses).
- Median progression-free survival was 2.5 months; median overall survival was 13.1 months.
- Grade 4 neutropenia occurred in 40% of patients.
Conclusions:
- The combination of tipifarnib and gemcitabine demonstrated poor tolerability due to high rates of myelosuppression.
- This combination did not show superior efficacy compared to gemcitabine monotherapy for metastatic breast cancer.
Related Concept Videos
Phase Diagrams
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Phase Transitions
Inductance: Single-Phase And Three-Phase Line
Single-Phase Two-Wire Line:
A single-phase line consists of two solid cylindrical conductors, denoted as x and y. Each conductor carries phasor currents ix and iy, respectively. Given that the sum of these currents is...
Capacitance: Single-Phase And Three-Phase Line
Single-Phase Lines
Consider a single-phase, two-wire transmission line with equal phase spacing energized by a voltage source. One conductor carries a uniform positive charge, while the other carries an equal negative charge. The capacitance C of the line can be derived from the voltage V between the conductors. For a one-meter section of the line, the capacitance is given...
Phase Changes
A substance melts or freezes at a temperature called its melting point and boils or condenses at its boiling point. These temperatures depend on pressure. High pressure favors the denser form of the substance, so typically, high pressure...

